Indian pharmaceutical stocks took a hit as Trump’s threat of imposing tariffs on pharma imports spooked investors. Despite India’s strong presence in the US generics market, potential tariffs may increase costs for US consumers and create supply chain challenges.
Ather Energy IPO crosses the line in final hours of Day 3; retail portion booked 1.55 times
Ather Energy’s Rs 3,000-crore IPO achieved full subscription on its final day, driven by strong institutional demand, although grey market signals remained weak. Retail investors
April 30, 2025